FDA’s Fall Regulatory Agenda Adds Several New Proposed and Final Rules Post author:PacConAdmin Post published:December 19, 2021 Post category:Drug Industry Daily The FDA’s fall 2021 regulatory agenda includes several new proposed and final rules. Source: Drug Industry Daily You Might Also Like Editor's Note May 25, 2017 Sandoz Makes U.S., European Headway With First Tysabri Biosimilar July 27, 2022 FDA Issues Final Guidance on Developing GnRH Analogues for Advanced Prostate Cancer May 26, 2022